Europe Cervical Cancer Diagnostic Testing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (PAP Testing, HPV Testing, Colposcopy, Cervical Biopsies, Cystoscopy, and Others) and Service Provider (Diagnostics and Research Laboratories, Hospitals and Clinics, Specialty Clinics, and Home Care Services)   

Code: TIPRE00027456 | Pages: 138 | Industry: Medical Device | Date: Mar 2022 | Type: Regional

The Europe cervical cancer diagnostic testing market is expected to grow from US$ 1,368.86 million in 2021 to US$ 1,881.38 million by 2028; it is estimated to grow at a CAGR of 4.6% from 2021 to 2028.

Precancerous changes can delay the disease progression, thus offering an extended time window for its treatment. However, due to a lack of awareness or access to diagnostic services, many cases are detected in the later stages of illness. Human papillomavirus (HPV), typically transmitted through sexual contact, is one of the primary causes of cervical cancer. Out of more than 100 HPV strains reported, 13 are high-risk or carcinogenic strains. The HPV test detects human papillomavirus in cervical cells. The active gene E6 or E7 determines whether an HPV strain is of high or low risk. Other screening methods employed in low-resource areas of several countries include HPV DNA testing and visual inspection. Cervical screening on a regular basis aid in the early detection of cervical cancer, lowering the mortality rate from the disease. According to National Cancer Institute, most women belonging to the age group 21–65 should undergo the Pap test while women from the age group 30–65 should undergo the Pap and HPV tests every three years. In terms of revenue, the HPV test dominates the cervical cancer screening market, and this trend is expected to continue during the forecast period, thereby driving the Europe market growth.

 

In case of COVID-19, Europe is highly affected specially the UK. The epidemic has caused a reduction in various medical procedures such as screening, follow-up, HPV triage tests, invasive diagnostic, and treatment of cervix-related indications. There is a need to create awareness among women about the advantages of early cervical cancer screening. The unwillingness of the patients to take the test is expected to have an undesired impact on the market in the region. However, global players such as Hologic Inc. in November 2021 launched Genius Digital Diagnostics System and are now commercially available in Europe. Thus, such active involvement of the international market players in the regional markets is expected to positively impact the region's market.

 

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe cervical cancer diagnostic testing market. The Europe cervical cancer diagnostic testing market is expected to grow at a good CAGR during the forecast period.   

 

Europe Cervical Cancer Diagnostic Testing Market Revenue and Forecast to 2028 (US$ Million)     

Europe Cervical Cancer Diagnostic Testing Market Revenue and Forecast to 2028 (US$ Million)     

Get more information on this report :

Europe Cervical Cancer Diagnostic Testing Market Segmentation        

Europe Cervical Cancer Diagnostic Testing Market – By Type

  • PAP Testing
  • HPV Testing
  • Colposcopy
  • Cervical Biopsies
  • Cystoscopy
  • Others

Europe Cervical Cancer Diagnostic Testing Market – By Service Provider

  • Diagnostics and Research Laboratories
  • Hospitals and Clinics
  • Specialty Clinics
  • Home Care Services

Europe Cervical Cancer Diagnostic Testing Market, by Country

  • Germany
  • UK 
  • France
  • Italy
  • Spain
  • Rest of Europe

Europe Cervical Cancer Diagnostic Testing Market - Companies Mentioned

  • Abbott
  • BD
  • Cooper Companies, Inc.
  • DYSIS Medical Inc
  • F. Hoffmann-La Roche Ltd.
  • Femasys Inc.
  • Guided Therapeutics, Inc
  • Hologic, Inc.
  • QIAGEN
  • Quest Diagnostics Incorporated   

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Europe Cervical Cancer Diagnostic Testing Market – By Type

1.3.2        Europe Cervical Cancer Diagnostic Testing Market – By Service Provider

1.3.3        Europe Cervical Cancer Diagnostic Testing Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Europe Cervical Cancer Diagnostic Testing Market – Market Landscape

4.1         Overview

4.2         Europe PEST Analysis

4.3         Experts Opinion

5.           Europe Cervical Cancer Diagnostic Testing Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Growing Prevalence of Cervical Cancer

5.1.2        Accelerating HPV Infections

5.2         Market Restraints

5.2.1        Less Awareness about the Diagnosis and Treatment Methods

5.3         Market Opportunities

5.3.1        Rising Development Opportunities in Emerging Countries

5.4         Future Trends

5.4.1        Increasing Development and Launch of Innovative Products

5.5         Impact Analysis

6.           Cervical Cancer Diagnostic Testing Market– Europe Analysis

6.1         Europe Cervical Cancer Diagnostic Testing Market Revenue Forecast and Analysis

7.           Europe Cervical Cancer Diagnostic Testing Market Analysis – By Type

7.1         Overview

7.2         Europe Cervical Cancer Diagnostic Testing Market, By Type, 2021 & 2028 (%)

7.3         PAP Testing

7.3.1        Overview

7.3.2        PAP Testing: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts to 2028 (US$ Million)

7.4         HPV Testing

7.4.1        Overview

7.4.2        HPV Testing: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts to 2028 (US$ Million)

7.5         Colposcopy

7.5.1        Overview

7.5.2        Colposcopy: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts to 2028 (US$ Million)

7.6         Cervical Biopsies

7.6.1        Overview

7.6.2        Cervical Biopsies: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts to 2028 (US$ Million)

7.7         Cystoscopy

7.7.1        Overview

7.7.2        Cystoscopy: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts to 2028 (US$ Million)

7.8         Others

7.8.1        Overview

7.8.2        Others: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts to 2028 (US$ Million)

8.           Europe Cervical Cancer Diagnostic Testing Market Analysis – By Service Provider

8.1         Overview

8.2         Europe Cervical Cancer Diagnostic Testing Market Share by Service Provider - 2021 & 2028 (%)

8.3         Diagnostics and Research Laboratories

8.3.1        Overview

8.3.2        Diagnostic Laboratories and Research Laboratories: Cervical Cancer Diagnostic Testing Market Revenue and Forecast to 2028 (US$ Million)

8.4         Hospitals and Clinics

8.4.1        Overview

8.4.2        Hospitals and Clinics: Cervical Cancer Diagnostic Testing Market Revenue and Forecast to 2028 (US$ Million)

8.5         Specialty Clinics

8.5.1        Overview

8.5.2        Specialty Clinics: Cervical Cancer Diagnostic Testing Market Revenue and Forecast to 2028 (US$ Million)

8.6         Home Care services

8.6.1        Overview

8.6.2        Home Care Services: Cervical Cancer Diagnostic Testing Market Revenue and Forecast to 2028 (US$ Million)

9.           Europe Cervical Cancer Diagnostic Testing Market – Country Analysis

9.1         Europe: Cervical Cancer Diagnostic Testing Market

9.1.1        Overview

9.1.3        Europe: Cervical Cancer Diagnostic Testing Market, by Country, 2021 & 2028 (%)

9.1.3.1          Germany: Cervical Cancer Diagnostic Testing Market – Revenue and Forecast to 2028 (US$ Million)

9.1.3.1.1          Overview

9.1.3.1.2          Germany: Cervical Cancer Diagnostic Testing Market – Revenue and Forecast to 2028 (US$ Million)

9.1.3.1.3          Germany: Cervical Cancer Diagnostic Testing Market, by Type – Revenue and Forecast to 2028 (US$ Million)

9.1.3.1.4          Germany: Cervical Cancer Diagnostic Testing Market, by Service Provider– Revenue and Forecast to 2028 (US$ Million)

9.1.3.2          France: Cervical Cancer Diagnostic Testing Market – Revenue and Forecast to 2028 (US$ Million)

9.1.3.2.1          Overview

9.1.3.2.2          France: Cervical Cancer Diagnostic Testing Market – Revenue and Forecast to 2028 (US$ Million)

9.1.3.2.3          France: Cervical Cancer Diagnostic Testing Market, by Type – Revenue and Forecast to 2028 (US$ Million)

9.1.3.2.4          France: Cervical Cancer Diagnostic Testing Market, by Service Provider– Revenue and Forecast to 2028 (US$ Million)

9.1.3.3          UK: Cervical Cancer Diagnostic Testing Market – Revenue and Forecast to 2028 (US$ Million)

9.1.3.3.1          Overview

9.1.3.3.2          UK: Cervical Cancer Diagnostic Testing Market – Revenue and Forecast to 2028 (US$ Million)

9.1.3.3.3          UK: Cervical Cancer Diagnostic Testing Market, by Type – Revenue and Forecast to 2028 (US$ Million)

9.1.3.3.4          UK: Cervical Cancer Diagnostic Testing Market, by Service Provider– Revenue and Forecast to 2028 (US$ Million)

9.1.3.4          Italy: Cervical Cancer Diagnostic Testing Market – Revenue and Forecast to 2028 (US$ Million)

9.1.3.4.1          Overview

9.1.3.4.2          Italy: Cervical Cancer Diagnostic Testing Market – Revenue and Forecast to 2028 (US$ Million)

9.1.3.4.3          Italy: Cervical Cancer Diagnostic Testing Market, by Type – Revenue and Forecast to 2028 (US$ Million)

9.1.3.4.4          Italy: Cervical Cancer Diagnostic Testing Market, by Service Provider– Revenue and Forecast to 2028 (US$ Million)

9.1.3.5          Spain: Cervical Cancer Diagnostic Testing Market – Revenue and Forecast to 2028 (US$ Million)

9.1.3.5.1          Overview

9.1.3.5.2          Spain: Cervical Cancer Diagnostic Testing Market – Revenue and Forecast to 2028 (US$ Million)

9.1.3.5.3          Spain: Cervical Cancer Diagnostic Testing Market, by Type – Revenue and Forecast to 2028 (US$ Million)

9.1.3.5.4          Spain: Cervical Cancer Diagnostic Testing Market, by Service Provider– Revenue and Forecast to 2028 (US$ Million)

9.1.3.6          Rest of Europe: Cervical Cancer Diagnostic Testing Market – Revenue and Forecast to 2028 (US$ Million)

9.1.3.6.1          Overview

9.1.3.6.2          Rest of Europe: Cervical Cancer Diagnostic Testing Market – Revenue and Forecast to 2028 (US$ Million)

9.1.3.6.3          Rest of Europe: Cervical Cancer Diagnostic Testing Market, by Type – Revenue and Forecast to 2028 (US$ Million)

9.1.3.6.4          Rest of Europe: Cervical Cancer Diagnostic Testing Market, by Service Provider– Revenue and Forecast to 2028 (US$ Million)

10.        Impact Of COVID-19 Pandemic on Europe Cervical Cancer Diagnostic Testing Market

10.1      Europe: Impact Assessment of COVID-19 Pandemic

11.        Europe Cervical Cancer Diagnostic Testing Market–Industry Landscape

11.1      Overview

11.2      Organic Developments

11.2.1     Overview

11.3      Inorganic Developments

11.3.1     Overview

12.        Company Profiles

12.1      F. Hoffmann-La Roche Ltd.

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      Abbott

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      Quest Diagnostics Incorporated

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      QIAGEN

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Hologic, Inc.

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      DYSIS Medical Inc

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      Femasys Inc.

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      Guided Therapeutics, Inc

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9      Cooper Companies, Inc.

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

12.10   BD

12.10.1  Key Facts

12.10.2  Business Description

12.10.3  Products and Services

12.10.4  Financial Overview

12.10.5  SWOT Analysis

12.10.6  Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

 


LIST OF TABLES

Table 1.             Europe Cervical Cancer Diagnostic Testing Market – Revenue and Forecast to 2028 (US$ Million)

Table 2.             Germany: Cervical Cancer Diagnostic Testing Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 3.             Germany: Cervical Cancer Diagnostic Testing Market, by Service Provider– Revenue and Forecast to 2028 (US$ Million)

Table 4.             France: Cervical Cancer Diagnostic Testing Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 5.             France: Cervical Cancer Diagnostic Testing Market, by Service Provider– Revenue and Forecast to 2028  (US$ Million)

Table 6.             UK: Cervical Cancer Diagnostic Testing Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 7.             UK: Cervical Cancer Diagnostic Testing Market, by Service Provider– Revenue and Forecast to 2028 (US$ Million)

Table 8.             Italy: Cervical Cancer Diagnostic Testing Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 9.             Italy: Cervical Cancer Diagnostic Testing Market, by Service Provider– Revenue and Forecast to 2028 (US$ Million)

Table 10.          Spain: Cervical Cancer Diagnostic Testing Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 11.          Spain: Cervical Cancer Diagnostic Testing Market, by Service Provider– Revenue and Forecast to 2028 (US$ Million)

Table 12.          Rest of Europe: Cervical Cancer Diagnostic Testing Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 13.          Rest of Europe: Cervical Cancer Diagnostic Testing Market, by Service Provider– Revenue and Forecast to 2028 (US$ Million)

Table 14.          Organic Developments

Table 15.          Inorganic Developments

Table 16.          Glossary of Terms

 


LIST OF FIGURES

Figure 1.           Europe Cervical Cancer Diagnostic Testing Market Segmentation

Figure 2.           Europe Cervical Cancer Diagnostic Testing Market, By Country

Figure 3.           Europe Cervical Cancer Diagnostic Testing Market Overview

Figure 4.           PAP Testing Segment Held Largest Share of the Market in 2021

Figure 5.           Germany is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           Europe: PEST Analysis

Figure 7.           Experts Opinion

Figure 8.           Impact Analysis of Drivers and Restraints Pertaining to Europe Cervical Cancer Diagnostic Testing Market

Figure 9.           Europe Cervical Cancer Diagnostic Testing Market Forecast to 2028

Figure 10.        Europe Cervical Cancer Diagnostic Testing Market, by Type, 2021 & 2028 (%)

Figure 11.        Europe Pap Testing: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 12.        Europe HPV Testing: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13.        Europe Colposcopy: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 14.        Europe Cervical Biopsies: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 15.        Europe Cystoscopy: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 16.        Europe Others: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 17.        Europe Cervical Cancer Diagnostic Testing Market Share by Service Provider - 2021 & 2028 (%)

Figure 18.        Europe Diagnostic Laboratories and Research Laboratories: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts To 2028 (US$ Million)

Figure 19.        Europe Hospitals and Clinics: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts To 2028 (US$ Million)

Figure 20.        Europe Specialty Clinics: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts To 2028 (US$ Million)

Figure 21.        Europe Home Care Services: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts To 2028 (US$ Million)

Figure 22.        Europe: Cervical Cancer Diagnostic Testing Market, by Key Country – Revenue (2021) (US$ Million)

Figure 23.        Europe: Cervical Cancer Diagnostic Testing Market, by Country, 2021 & 2028 (%)

Figure 24.        Germany: Cervical Cancer Diagnostic Testing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        France: Cervical Cancer Diagnostic Testing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        UK: Cervical Cancer Diagnostic Testing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Italy: Cervical Cancer Diagnostic Testing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Spain: Cervical Cancer Diagnostic Testing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.        Rest of Europe: Cervical Cancer Diagnostic Testing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30.        Impact of COVID-19 Pandemic in European Country Markets

  1. Abbott
  2. BD
  3. Cooper Companies, Inc.
  4. DYSIS Medical Inc
  5. F. Hoffmann-La Roche Ltd.
  6. Femasys Inc.
  7. Guided Therapeutics, Inc
  8. Hologic, Inc.
  9. QIAGEN
  10. Quest Diagnostics Incorporated     
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
Site License
$4000
Enterprise License
$5000